BHCM
REPL icon

Brevan Howard Capital Management’s Replimune Group REPL Stock Holding History

Brevan Howard Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,893
Closed -$275K – 2495
2026
Q1 		$275K Sell
35,893
-17,068
-32% -$130K ﹤0.01% 1681
2025
Q4 		$515K Hold
52,961
– – 0.01% 1101
2025
Q3 		$222K Sell
52,961
-5,281
-9% -$33.7K ﹤0.01% 1708
2025
Q2 		$541K Buy
+58,242
New +$508K ﹤0.01% 1327
2024
Q3 		– Sell
-39,170
Closed -$353K – 1382
2024
Q2 		$353K Buy
39,170
+20,999
+116% +$146K ﹤0.01% 724
2024
Q1 		$148K Buy
+18,171
New +$149K ﹤0.01% 849

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Brevan Howard Capital Management's REPL Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 35,893 shares — an estimated $275K sold.

Brevan Howard Capital Management first reported a position in REPL in Q1 2024 and held it in 6 quarters. The position peaked at $541K in Q2 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 35,893 Replimune Group shares in Q2 2026, an estimated $275K.
  • Brevan Howard Capital Management first reported a position in Replimune Group in Q1 2024 and held it in 6 quarters.
  • Brevan Howard Capital Management's Replimune Group position peaked at $541K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.